Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPrimary Health Regulatory News (PHP)

Share Price Information for Primary Health (PHP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 92.55
Bid: 92.45
Ask: 92.65
Change: -1.50 (-1.59%)
Spread: 0.20 (0.216%)
Open: 94.35
High: 94.35
Low: 92.50
Prev. Close: 94.05
PHP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Capital Raising

18 Apr 2018 07:00

RNS Number : 2444L
Primary Health Properties PLC
18 April 2018
 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED IN IT IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, NEW ZEALAND OR THE REPUBLIC OF SOUTH AFRICA OR INTO ANY OTHER JURISDICTION WHERE TO DO SO MIGHT CONSTITUTE A VIOLATION OR BREACH OF ANY APPLICABLE LAW. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT.

 

THIS ANNOUNCEMENT IS AN ADVERTISEMENT AND DOES NOT CONSTITUTE A PROSPECTUS OR PROSPECTUS EQUIVALENT DOCUMENT. NOTHING HEREIN SHALL CONSTITUTE AN OFFERING OF NEW SHARES. ANY DECISION TO PURCHASE, SUBSCRIBE FOR, OTHERWISE ACQUIRE, SELL OR OTHERWISE DISPOSE OF ANY NEW SHARES MUST BE MADE ONLY ON THE BASIS OF THE INFORMATION CONTAINED IN AND INCORPORATED BY REFERENCE INTO THE PROSPECTUS.

 

18 April 2018

 

Primary Health Properties PLC

("PHP" or the "Company")

 

Result of Capital Raising

 

On 23 March 2018, PHP announced a proposed Firm Placing and Placing, Open Offer and Offer for Subscription at 108 pence per share (the "Capital Raising").

 

PHP is now pleased to announce that it has received valid applications and commitments for the Capital Raising such that the Company will issue 106,481,482 New Shares at 108 pence per share, raising £115.0 million and exceeding its initial fundraising target of up to £100 million. The issue of these New Shares is subject to shareholder approval of the Capital Raising at today's General Meeting. The issue of New Shares will be split as follows:

 

· 46,296,296 New Shares under the Firm Placing, raising gross proceeds of £50.0 million;

 

· 30,017,790 New Shares taken up under the Open Offer, including excess applications, raising gross proceeds of £32.4 million;

 

· 25,817,826 New Shares under the Placing raising gross proceeds of £27.9 million; and

 

· 4,349,570 New Shares under the Offer for Subscription raising gross proceeds of £4.7 million.

 

Applications under the Open Offer (including excess applications) and the Offer for Subscription will all be met in full.

 

A General Meeting of the Company is to be held at 10.45 a.m. today (or as soon thereafter as the annual general meeting convened for 10.30 a.m. concludes) at CMS Cameron McKenna Nabarro Olswang LLP, Cannon Place, 78 Cannon Street, London EC4N 6AF, at which the Resolutions set out in the notice of general meeting dated 23 March 2018 will be proposed.

 

Harry Hyman, Managing Director of PHP, said:

 

"I am delighted to report the success of the Company's £115.0 million fundraise and on behalf of the Board, would like to thank existing and new shareholders for their support. Once again the fundraise has attracted a diversified range of high-quality investors, as well as being well received by existing shareholders with 82% take up under the Open Offer. This demonstrates that investors firmly believe in the need to deliver an increased number of next-generation health services to local communities in the UK and Republic of Ireland, supporting the modernisation of primary care services and alleviating the growing pressure on the NHS and state-funded healthcare services in Ireland.

 

"The proceeds will enable PHP to grow its portfolio and the Board believes the pipeline of acquisition targets will deliver significant returns to shareholders. PHP continues to demonstrate its value as a growing long-term investment opportunity which, supported by ever-stronger market fundamentals, will continue to deliver significant returns."

 

Miscellaneous

 

The Capital Raising remains conditional upon the Resolutions being passed by Shareholders at the general meeting today, the Placing Agreement becoming unconditional in all respects and Admission. Application has been made for the admission of the 106,481,482 New Shares to the Official List of the Financial Conduct Authority ("FCA") and to trading on the premium segment of the London Stock Exchange's main market for listed securities. It is expected that Admission and commencement of dealings in the New Shares will become effective at 8.00 a.m. on 19 April 2018.

 

New Shares in uncertificated form are expected to be credited to CREST accounts by 8.00 a.m. on 19 April 2018 and definitive share certificates for the New Shares in certificated form are expected to be dispatched no later than 30 April 2018.

 

The New Shares, when issued and fully paid, will rank in full for all dividends or distributions made, paid or declared, if any, by reference to a record date after the date of their issue or otherwise pari passu in all respects with the Existing Ordinary Shares. The New Shares will not qualify for the dividend declared on 27 March 2018, payable on 25 May 2018 to Shareholders on the Company's register as at 6 April 2018.

 

Following Admission, the total issued share capital of PHP will be 730,732,852 Ordinary Shares of 12.5 pence each. This figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Capitalised terms used in this announcement have the meanings given to them in the prospectus issued by the Company, dated 23 March 2018.

 

For further information contact:

 

Primary Health Properties PLC

+44(0) 20 7451 7050

Harry Hyman, Managing Director

Richard Howell, Finance Director

Buchanan PR

+44(0) 207 7466 5000

David Rydell / Stephanie Watson/ Tilly Abraham

Numis Securities Limited

Sole Sponsor, Joint Broker and Joint Bookrunner

+44(0) 20 7260 1000

Corporate Finance: Michael Meade / Kevin Cruickshank

Corporate Broking: James Black / Jamie Loughborough

Peel Hunt

Joint Broker and Joint Bookrunner

+44(0) 20 7418 8900

Corporate Finance: Capel Irwin / Carl Gough / Harry Nicholas

ECM Syndicate: Jock Maxwell Macdonald / Sohail Akbar

 

Legal Entity Identifier: 213800Y5CJHXOATK7X11

 

IMPORTANT NOTICE

 

This announcement does not constitute or form part of any offer or invitation to purchase, or otherwise acquire, subscribe for, sell, otherwise dispose of or issue, or any solicitation of any offer to sell, otherwise dispose of, issue, purchase, otherwise acquire or subscribe for, any security in the capital of the Company in any jurisdiction.

 

The information contained in this announcement is not for release, publication or distribution to persons in the United States, Canada, Australia, Japan, New Zealand or the Republic of South Africa or in any jurisdiction where to do so would breach any applicable law. The New Shares have not been and will not be registered under the securities laws of such jurisdictions and may not be offered, sold, taken up, exercised, resold, renounced, transferred or delivered, directly or indirectly, within such jurisdictions except pursuant to an exemption from and in compliance with any applicable securities laws. No public offer of the New Shares is being made by virtue of this announcement in or into the United States, Australia, Canada, Japan, New Zealand or the Republic of South Africa or any other jurisdiction outside the United Kingdom in which such offer would be unlawful. No action has been or will be taken by the Company, Numis, Peel Hunt or any other person to permit a public offering or distribution of this announcement or any other offering or publicity materials or the New Shares in any jurisdiction where action for that purpose may be required, other than in the United Kingdom.

 

The New Shares and any entitlements pursuant to the open offer and offer for subscription will not be registered under the US Securities Act of 1933, as amended (the "US Securities Act"), or with the securities regulatory authority of any state or other jurisdiction of the United States. Unless so registered, the New Shares and any entitlements pursuant to the open offer and offer for subscription may not be offered, sold, taken up or exercised, within the United States except in a transaction that is exempt from, the registration requirements of the US Securities Act. There will be no public offer of New Shares in the United States. Outside the United States, the New Shares are being offered in reliance on Regulation S under the US Securities Act.

 

This announcement has been issued by and is the sole responsibility of the Company.

 

Numis Securities Limited, which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting for Primary Health Properties PLC and for no-one else in connection with the Capital Raising and will not be responsible to anyone other than Primary Health Properties PLC for providing the protections afforded to clients of Numis Securities Limited, or for providing advice in relation to the Capital Raising or any matters referred to in this announcement. Numis Securities Limited is not responsible for the contents of this announcement.

 

Peel Hunt LLP, which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting for Primary Health Properties PLC and for no-one else in connection with the Capital Raising and will not be responsible to anyone other than Primary Health Properties PLC for providing the protections afforded to clients of Peel Hunt LLP, or for providing advice in relation to the Capital Raising or any matters referred to in this announcement. Peel Hunt LLP is not responsible for the contents of this announcement.

 

This announcement has been prepared for the purposes of complying with the applicable laws and regulations of the United Kingdom and the information disclosed may not be the same as that which would have been disclosed if this announcement had been prepared in accordance with the laws and regulations of any jurisdiction outside of the United Kingdom.

 

Neither the content of the Company's website (or any other website) nor any website accessible by hyperlinks on the Company's website (or any other website) is incorporated in, or forms part of, this announcement.

 

Any person receiving this announcement is advised to exercise caution in relation to the Capital Raising. If in any doubt about any of the contents of this announcement, independent professional advice should be obtained.

 

This announcement is not for publication or distribution, directly or indirectly, in or into the United States of America. This announcement is not an offer of securities for sale into the United States. The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended, and may not be offered or sold in the United States, except pursuant to an applicable exemption from registration. No public offering of securities is being made in the United States.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ROIBDLLFVZFLBBL
Date   Source Headline
20th May 20249:00 amRNSDirector/PDMR Shareholding
9th May 20242:00 pmRNSDirector/PDMR Shareholding
26th Apr 20243:00 pmRNSDirector/PDMR Shareholding
24th Apr 20241:50 pmRNSResults of AGM voting
8th Apr 20248:30 amRNSDirector/PDMR Shareholding
3rd Apr 202411:00 amRNSDirector/PDMR Shareholding
28th Mar 202412:15 pmRNSAmendment of exchange price on Convertible Bonds
21st Mar 20247:00 amRNSNotice of Interim Dividend
20th Mar 202410:00 amRNSDirector/PDMR Shareholding
19th Mar 20247:00 amRNSDirector/PDMR Shareholding
13th Mar 20241:00 pmRNSDirector/PDMR Shareholding
13th Mar 20241:00 pmRNSDirector/PDMR Shareholding
13th Mar 202411:30 amRNSAnnual Financial Report
8th Mar 20247:00 amRNSDirector/PDMR Shareholding
8th Mar 20247:00 amRNSDirector/PDMR Shareholding
7th Mar 20247:00 amRNSDirector/PDMR Shareholding
6th Mar 20243:30 pmRNSDirector/PDMR Shareholding
1st Mar 20242:00 pmRNSDirector/PDMR Shareholding
29th Feb 20242:30 pmRNSDirector/PDMR Shareholding
28th Feb 20249:30 amRNSDirector/PDMR Shareholding
28th Feb 20249:30 amRNSDirector/PDMR Shareholding
28th Feb 20247:02 amRNSBoard Change
28th Feb 20247:00 amRNSPreliminary Results
26th Feb 20249:00 amRNSDirector Shareholding
2nd Feb 202410:10 amRNSHolding(s) in Company
22nd Jan 20247:00 amRNSChange of Time: Preliminary Results
12th Jan 20247:00 amRNSNotice of Preliminary Results
5th Jan 202411:00 amRNSUpdate for Shareholders on the SA Register
4th Jan 20247:00 amRNSNotice of Interim Dividend
14th Dec 20239:30 amRNSDirector/PDMR Shareholding
14th Dec 20239:30 amRNSDirector/PDMR Shareholding
27th Nov 202310:02 amRNSDirector/PDMR Shareholding
8th Nov 202310:00 amRNSPurchase of Shares by Employee Benefit Trust
2nd Nov 20237:00 amRNSChairman Appointment
24th Oct 20238:01 amRNSQ3 Trading Update, Completion of Secondary Listing
17th Oct 20238:00 amRNSUpdate on secondary listing on the JSE
12th Oct 20233:07 pmRNSAmendment of exchange price on Convertible Bonds
5th Oct 20237:00 amRNSNotice of Interim Dividend
25th Sep 202312:16 pmRNSHolding(s) in Company
14th Sep 20233:53 pmRNSDirector/PDMR Shareholding
14th Sep 20233:51 pmRNSDirector/PDMR Shareholding
13th Sep 20237:00 amRNSPHP makes largest single Irish acquisition to date
6th Sep 20237:00 amRNSSecondary Listing on the JSE
4th Sep 20237:00 amRNSChief Executive Officer Appointment
21st Aug 20239:26 amRNSDirector shareholding
15th Aug 20237:00 amRNSInvestor webinar hosted by Capital Access Group
11th Aug 20237:15 amRNSEdison issues update on Primary Health Properties
27th Jul 202312:25 pmRNSDirector/PDMR Shareholding
26th Jul 20237:00 amRNSInterim Results
6th Jul 20231:50 pmRNSAmendment of exchange price on Convertible Bonds

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.